The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Open accessAbstract
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically, CIPN is a mostly sensory neuropathy that may be accompanied by motor and autonomic changes of varying intensity and duration. Due to its high prevalence among cancer patients, CIPN constitutes a major problem for both cancer patients and survivors as well as for their health care providers, especially because, at the moment, there is no single effective method of preventing CIPN; moreover, the possibilities of treating this syndrome are very limited. There are six main substance groups that cause damage to peripheral sensory, motor and autonomic neurons, which result in the development of CIPN: platinum-based antineoplastic agents, vinca alkaloids, epothilones (ixabepilone), taxanes, proteasome inhibitors (bortezomib) and immunomodulatory drugs (thalidomide). Among them, the most neurotoxic are platinum-based agents, taxanes, ixabepilone and thalidomide; other less neurotoxic but also commonly used drugs are bortezomib and vinca alkaloids. This paper reviews the clinical picture of CIPN and the neurotoxicity mechanisms of the most common antineoplastic agents. A better understanding of the risk factors and underlying mechanisms of CIPN is needed to develop effective preventive and therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Metals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.020 · Cited by 1,555
Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0914 · Cited by 1,209
Immunogenic death of colon cancer cells treated with oxaliplatin
Tesniere, A., Schlemmer, F., Boige, V, Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,173
Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.-Y., Sack, M. N., Kastner, D. L., & Siegel, R. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102049 · Cited by 860
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S., Friedlander, M. L., Cassidy, J., Koltzenburg, M., & Kiernan, M. C. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21204 · Cited by 741
de Moor, J. S., Mariotto, A. B., Parry, C., Alfano, C. M., Padgett, L., Kent, E. E., Forsythe, L., Scoppa, S., Hachey, M., & Rowland, J. H. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1356 · Cited by 670 · cited 1×
“7 million in 2012 to 18 million, by 2022 [2].”
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Starobova, H., & Vetter, I. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00174 · Cited by 648
Flatters, S. J. L., & Bennett, G. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.037 · Cited by 535
Jin, X., & Gereau, R. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3858-05.2006 · Cited by 486
Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity
Keifer, J. A., Guttridge, D. C., Ashburner, B. P., & Jr.Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100938200 · Cited by 478
Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
Areti, A., Yerra, V. G., Naidu, V., & Kumar, A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.006 · Cited by 456
Axon degeneration: Molecular mechanisms of a self-destruction pathway
Wang, J. T., Medress, Z. A., & Barres, B. A. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201108111 · Cited by 442
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
Carozzi, V. A., Canta, A., & Chiorazzi, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.014 · Cited by 431
Dawkins, J. L., Hulme, D. J., Brahmbhatt, S. B., Auer-Grumbach, M., & Nicholson, G. A. (2001) · Nature Genetics · doi:10.1038/85879 · Cited by 423
Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy
Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.010 · Cited by 408
Flatters, S. J. L., Dougherty, P. M., & Colvin, L. A. (2017) · British Journal of Anaesthesia · doi:10.1093/bja/aex229 · Cited by 391
Descoeur, J., Pereira, V., Pizzoccaro, A., Francois, A., Ling, B., Maffre, V., Couette, B., Busserolles, J., Courteix, C., Noel, J., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100134 · Cited by 368
Zhang, H., Li, Y., de Carvalho-Barbosa, M., Kavelaars, A., Heijnen, C. J., Albrecht, P. J., & Dougherty, P. M. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2016.02.011 · Cited by 365
Gregg, R. W., Molepo, J. M., Monpetit, V. J., Mikael, N. Z., Redmond, D., Gadia, M., & Stewart, D. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.795 · Cited by 358
Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy
Jaggi, A. S., & Singh, N. (2012) · Toxicology · doi:10.1016/j.tox.2011.10.019 · Cited by 358
Kerckhove, N., Collin, A., Condé, S., Chaleteix, C., Pezet, D., & Balayssac, D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00086 · Cited by 350
An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status
Janelsins, M. C., Kohli, S., Mohile, S. G., Usuki, K., Ahles, T. A., & Morrow, G. R. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.03.014 · Cited by 342
Argaw, A. T., Zhang, Y., Snyder, B. J., Zhao, M.-L., Kopp, N., Lee, S. C., Raine, C. S., Brosnan, C. F., & John, G. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5574 · Cited by 339
Glare, P. A., Davies, P. S., Finlay, E., Gulati, A., Lemanne, D., Moryl, N., Oeffinger, K. C., Paice, J. A., Stubblefield, M. D., & Syrjala, K. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4629 · Cited by 329 · cited 1×
“Although these survivors may have beaten cancer, many of them have poor outcomes due to a number of syndromes that reduce the quality of life as a consequence of cancer treatment, including pain, which they often experience for a long time after completing their cancer treatment [3].”
BackgroundFallon, M. T. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet208 · Cited by 327
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation
Nassini, R., Gees, M., Harrison, S., De Siena, G., Materazzi, S., Moretto, N., Failli, P., Preti, D., Marchetti, N., Cavazzini, A., et al. (2011) · Pain · doi:10.1016/j.pain.2011.02.051 · Cited by 324
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Scripture, C., Figg, W., & Sparreboom, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359568 · Cited by 320
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
Podratz, J. L., Knight, A. M., Ta, L. E., Staff, N. P., Gass, J. M., Genelin, K., Schlattau, A., Lathroum, L., & Windebank, A. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.017 · Cited by 320
Chen, Y., Yang, C., & Wang, Z. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.085 · Cited by 302
SIAU, C., XIAO, W., & BENNETT, G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.007 · Cited by 300
Vincristine‐induced neuropathy: A clinical study of fifty leukemic patients
Sandier, S. G., Tobin, W., & Henderson, E. S. (1969) · Neurology · doi:10.1212/wnl.19.4.367 · Cited by 300
VINCRISTINE NEUROPATHY: CLINICAL AND ELECTROPHYSIOLOGICAL OBSERVATIONS
CASEY, E. B., JELLIFE, A. M., LE QUESNE, P. M., & MILLETT, Y. L. (1973) · Brain · doi:10.1093/brain/96.1.69 · Cited by 293
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
Adelsberger, H., Quasthoff, S., Grosskreutz, J., Lepier, A., Eckel, F., & Lersch, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00667-1 · Cited by 290
Diouf, B., Crews, K. R., Lew, G., Pei, D., Cheng, C., Bao, J., Zheng, J. J., Yang, W., Fan, Y., Wheeler, H. E., et al. (2015) · JAMA · doi:10.1001/jama.2015.0894 · Cited by 278
The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling
Kolb, N. A., Smith, A. G., Singleton, J. R., Beck, S. L., Stoddard, G. J., Brown, S., & Mooney, K. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0383 · Cited by 276
Zheng, H., Xiao, W. H., & Bennett, G. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.016 · Cited by 272
Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
Geisler, S., Doan, R. A., Strickland, A., Huang, X., Milbrandt, J., & DiAntonio, A. (2016) · Brain · doi:10.1093/brain/aww251 · Cited by 270
Rochfort, K. D., Collins, L. E., Murphy, R. P., & Cummins, P. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101815 · Cited by 261
Makker, P. G. S., Duffy, S. S., Lees, J. G., Perera, C. J., Tonkin, R. S., Butovsky, O., Park, S. B., Goldstein, D., & Moalem-Taylor, G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170814 · Cited by 254
The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions
Gornstein, E., & Schwarz, T. L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.016 · Cited by 252
Update on taxane development: new analogs and new formulations
Tkaczuk, K., & Yared, J. (2012) · Drug Design, Development and Therapy · doi:10.2147/dddt.s28997 · Cited by 247
Li, Y., North, R. Y., Rhines, L. D., Tatsui, C. E., Rao, G., Edwards, D. D., Cassidy, R. M., Harrison, D. S., Johansson, C. A., Zhang, H., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0899-17.2017 · Cited by 247
Toll-Like Receptor 4 Signaling Contributes to Paclitaxel-Induced Peripheral Neuropathy
Li, Y., Zhang, H., Zhang, H., Kosturakis, A. K., Jawad, A. B., & Dougherty, P. M. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.04.001 · Cited by 244
Materazzi, S., Fusi, C., Benemei, S., Pedretti, P., Patacchini, R., Nilius, B., Prenen, J., Creminon, C., Geppetti, P., & Nassini, R. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1071-x · Cited by 224
Argyriou, A. A., Cavaletti, G., Briani, C., Velasco, R., Bruna, J., Campagnolo, M., Alberti, P., Bergamo, F., Cortinovis, D., Cazzaniga, M., et al. (2013) · Cancer · doi:10.1002/cncr.27732 · Cited by 221
The contribution of satellite glial cells to chemotherapy‐induced neuropathic pain
Warwick, R. A., & Hanani, M. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00219.x · Cited by 221
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy
Wang, X.-M., Lehky, T. J., Brell, J. M., & Dorsey, S. G. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.027 · Cited by 220
LaPointe, N. E., Morfini, G., Brady, S. T., Feinstein, S. C., Wilson, L., & Jordan, M. A. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.05.008 · Cited by 219
Broyl, A., Corthals, S. L., Jongen, J. L., van der Holt, B., Kuiper, R., de Knegt, Y., van Duin, M., el Jarari, L., Bertsch, U., Lokhorst, H. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70206-0 · Cited by 219
Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721
Mollman, J. E., Glover, D. J., Hogan, W. M., & FURMAN, R. E. (1988) · Cancer · doi:10.1002/1097-0142(19880601)61:11<2192::aid-cncr2820611110>3.0.co;2-a · Cited by 219
Badros, A., Goloubeva, O., Dalal, J. S., Can, I., Thompson, J., Rapoport, A. P., Heyman, M., Akpek, G., & Fenton, R. G. (2007) · Cancer · doi:10.1002/cncr.22921 · Cited by 217
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Canta, A., Pozzi, E., & Carozzi, V. (2015) · Toxics · doi:10.3390/toxics3020198 · Cited by 215
7. MEDICINAL CHEMISTRY OF GOLD ANTICANCER METALLODRUGS
Casini, A., Wai-Yin Sun, R., & Ott, I. (2018) · Metallo-Drugs: Development and Action of Anticancer Agents · doi:10.1515/9783110470734-007 · Cited by 215
Zhang, H., Yoon, S.-Y., Zhang, H., & Dougherty, P. M. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2011.12.002 · Cited by 213
Joseph, E. K., Chen, X., Bogen, O., & Levine, J. D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2008.01.335 · Cited by 210
Sittl, R., Lampert, A., Huth, T., Schuy, E. T., Link, A. S., Fleckenstein, J., Alzheimer, C., Grafe, P., & Carr, R. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118058109 · Cited by 209
Kidd, J. F., Pilkington, M. F., Schell, M. J., Fogarty, K. E., Skepper, J. N., Taylor, C. W., & Thorn, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106802200 · Cited by 205
Krukowski, K., Eijkelkamp, N., Laumet, G., Hack, C. E., Li, Y., Dougherty, P. M., Heijnen, C. J., & Kavelaars, A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3708-15.2016 · Cited by 203
Boyette-Davis, J., Xin, W., Zhang, H., & Dougherty, P. M. (2011) · Pain · doi:10.1016/j.pain.2010.10.030 · Cited by 202
Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility
Park, S. B., Lin, C. S. Y., Krishnan, A. V., Goldstein, D., Friedlander, M. L., & Kiernan, M. C. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0248 · Cited by 198
Chemotherapy‐induced neuropathies—a growing problem for patients and health care providers
Banach, M., Juranek, J. K., & Zygulska, A. L. (2017) · Brain and Behavior · doi:10.1002/brb3.558 · Cited by 197
Attal, N., Bouhassira, D., Gautron, M., Vaillant, J. N., Mitry, E., Lepère, C., Rougier, P., & Guirimand, F. (2009) · Pain · doi:10.1016/j.pain.2009.03.024 · Cited by 195
Li, Y., Tatsui, C. E., Rhines, L. D., North, R. Y., Harrison, D. S., Cassidy, R. M., Johansson, C. A., Kosturakis, A. K., Edwards, D. D., Zhang, H., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000774 · Cited by 195
Mannelli, L. D. C., Zanardelli, M., Failli, P., & Ghelardini, C. (2012) · Journal of Pain · doi:10.1016/j.jpain.2011.11.009 · Cited by 194
Sakurai, M., Egashira, N., Kawashiri, T., Yano, T., Ikesue, H., & Oishi, R. (2009) · Pain · doi:10.1016/j.pain.2009.09.003 · Cited by 193
Ta, L. E., Bieber, A. J., Carlton, S. M., Loprinzi, C. L., Low, P. A., & Windebank, A. J. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-15 · Cited by 193
MCP-1 Enhances Excitability of Nociceptive Neurons in Chronically Compressed Dorsal Root Ganglia
Sun, J. H., Yang, B., Donnelly, D. F., Ma, C., & LaMotte, R. H. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00222.2006 · Cited by 192
Xiao, W. H., & Bennett, G. J. (2012) · Pain · doi:10.1016/j.pain.2011.12.011 · Cited by 191
Topp, K. S., Tanner, K. D., & Levine, J. D. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000904)424:4<563::aid-cne1>3.0.co;2-u · Cited by 189
Zhao, M., Isami, K., Nakamura, S., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-55 · Cited by 189
Beijers, A. J. M., Mols, F., & Vreugdenhil, G. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2242-z · Cited by 189
Duggett, N. A., Griffiths, L. A., McKenna, O. E., de Santis, V., Yongsanguanchai, N., Mokori, E. B., & Flatters, S. J. L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.050 · Cited by 189
Leonard, G. D., Wright, M. A., Quinn, M. G., Fioravanti, S., Harold, N., Schuler, B., Thomas, R. R., & Grem, J. L. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-116 · Cited by 184
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy
Zheng, H., Xiao, W. H., & Bennett, G. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.023 · Cited by 184
Dysregulation of Cellular Calcium Homeostasis in Chemotherapy-Evoked Painful Peripheral Neuropathy
Siau, C., & Bennett, G. J. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000204318.35194.ed · Cited by 183
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy
Lees, J. G., Makker, P. G. S., Tonkin, R. S., Abdulla, M., Park, S. B., Goldstein, D., & Moalem-Taylor, G. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.006 · Cited by 176
Morphologic Features and Glial Activation in Rat Oxaliplatin-Dependent Neuropathic Pain
Di Cesare Mannelli, L., Pacini, A., Bonaccini, L., Zanardelli, M., Mello, T., & Ghelardini, C. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.08.002 · Cited by 175
Xiao, W. H., Zheng, H., Zheng, F. Y., Nuydens, R., Meert, T. F., & Bennett, G. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.010 · Cited by 175
The State of Cancer Care in America, 2014: A Report by the American Society of Clinical Oncology
American Society of Clinical Oncology (2014) · Journal of Oncology Practice · doi:10.1200/jop.2014.001386 · Cited by 174
Deuis, J. R., Zimmermann, K., Romanovsky, A. A., Possani, L. D., Cabot, P. J., Lewis, R. J., & Vetter, I. (2013) · Pain · doi:10.1016/j.pain.2013.05.032 · Cited by 171
Chemotherapy, cognitive impairment and hippocampal toxicity
Dietrich, J., Prust, M., & Kaiser, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.016 · Cited by 169
Bernhardson, B.-M., Tishelman, C., & Rutqvist, L. E. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.12.010 · Cited by 169
Zhang, H., & Dougherty, P. M. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000176 · Cited by 169
Glial role in oxaliplatin-induced neuropathic pain
Di Cesare Mannelli, L., Pacini, A., Micheli, L., Tani, A., Zanardelli, M., & Ghelardini, C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.016 · Cited by 168
Doyle, T., Chen, Z., Muscoli, C., Bryant, L., Esposito, E., Cuzzocrea, S., Dagostino, C., Ryerse, J., Rausaria, S., Kamadulski, A., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6343-11.2012 · Cited by 168
Mohty, B., El-Cheikh, J., Yakoub-Agha, I., Moreau, P., Harousseau, J.-L., & Mohty, M. (2010) · Haematologica · doi:10.3324/haematol.2009.012674 · Cited by 167
Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations
Abdi, S. (2018) · Pain Physician · doi:10.36076/ppj.2018.6.571 · Cited by 167
Robinson, C., Zhang, H., & Dougherty, P. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.051 · Cited by 164
Mironov, S. L., Ivannikov, M. V., & Johansson, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409819200 · Cited by 164
Taxol Neuropathy: Electrodiagnostic and Sural Nerve Biopsy Findings
Sahenk, Z. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540190110024 · Cited by 163
Eckhoff, L., Knoop, A., Jensen, M., & Ewertz, M. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.11.024 · Cited by 163
Boehmerle, W., Huehnchen, P., Peruzzaro, S., Balkaya, M., & Endres, M. (2014) · Scientific Reports · doi:10.1038/srep06370 · Cited by 159
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Stockstill, K., Doyle, T. M., Yan, X., Chen, Z., Janes, K., Little, J. W., Braden, K., Lauro, F., Giancotti, L. A., Harada, C. M., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170584 · Cited by 158
Boehmerle, W., Splittgerber, U., Lazarus, M. B., McKenzie, K. M., Johnston, D. G., Austin, D. J., & Ehrlich, B. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607240103 · Cited by 153
Zhang, H., Boyette-Davis, J. A., Kosturakis, A. K., Li, Y., Yoon, S. Y., Walters, E. T., & Dougherty, P. M. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.03.012 · Cited by 153
Gornstein, E. L., & Schwarz, T. L. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.015 · Cited by 150
Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion
Hara, T., Chiba, T., Abe, K., Makabe, A., Ikeno, S., Kawakami, K., Utsunomiya, I., Hama, T., & Taguchi, K. (2013) · Pain · doi:10.1016/j.pain.2013.02.023 · Cited by 142
Janes, K., Wahlman, C., Little, J. W., Doyle, T. M., Tosh, D. K., Jacobson, K. A., & Salvemini, D. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.010 · Cited by 142
Duggett, N. A., Griffiths, L. A., & Flatters, S. J. L. (2017) · Pain · doi:10.1097/j.pain.0000000000000939 · Cited by 140
Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
Imai, S., Koyanagi, M., Azimi, Z., Nakazato, Y., Matsumoto, M., Ogihara, T., Yonezawa, A., Omura, T., Nakagawa, S., Wakatsuki, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05784-1 · Cited by 129
Spinal Astrocyte Gap Junctions Contribute to Oxaliplatin-Induced Mechanical Hypersensitivity
Yoon, S. Y., Robinson, C. R., Zhang, H., & Dougherty, P. M. (2013) · Journal of Pain · doi:10.1016/j.jpain.2012.11.002 · Cited by 128
Shemesh, O. A., & Spira, M. E. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0586-0 · Cited by 128
Liu, C., Lü, N., Cui, Y., Yang, T., Zhao, Z., Xin, W., & Liu, X. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-76 · Cited by 125
Chemotherapy-induced neuropathic pain
Farquhar-Smith, P. W. (2010) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328342f9cc · Cited by 124
Kawashiri, T., Egashira, N., Kurobe, K., Tsutsumi, K., Yamashita, Y., Ushio, S., Yano, T., & Oishi, R. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-7 · Cited by 122
Okubo, K., Takahashi, T., Sekiguchi, F., Kanaoka, D., Matsunami, M., Ohkubo, T., Yamazaki, J., Fukushima, N., Yoshida, S., & Kawabata, A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.004 · Cited by 121
Argyriou, A. A., Cavaletti, G., Antonacopoulou, A. G., Genazzani, A. A., Briani, C., Bruna, J., Terrazzino, S., Velasco, R., Alberti, P., Campagnolo, M., et al. (2013) · Cancer · doi:10.1002/cncr.28234 · Cited by 115
Branca, J. J. V., Maresca, M., Morucci, G., Becatti, M., Paternostro, F., Gulisano, M., Ghelardini, C., Salvemini, D., Mannelli, L. D. C., & Pacini, A. (2018) · Oncotarget · doi:10.18632/oncotarget.25193 · Cited by 114
Maestri, A., Ceratti, A. D. P., Cundari, S., Zanna, C., Cortesi, E., & Crinò, L. (2005) · Tumori Journal · doi:10.1177/030089160509100206 · Cited by 113
Chemotherapy-Induced Neuropathy
Cavaletti, G., Alberti, P., Frigeni, B., Piatti, M., & Susani, E. L. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0108-3 · Cited by 110
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells
Tamilarasan, K. P., Kolluru, G. K., Rajaram, M., Indhumathy, M., Rajendran, S., & Chatterjee, S. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-17 · Cited by 109
Role of MAPKs in platinum-induced neuronal apoptosis
Scuteri, A., Galimberti, A., Maggioni, D., Ravasi, M., Pasini, S., Nicolini, G., Bossi, M., Miloso, M., Cavaletti, G., & Tredici, G. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.01.003 · Cited by 109
An Updated Understanding of the Mechanisms Involved in cHemotherapy-Induced Neuropathy
Boyette-Davis, J. A., Hou, S., Abdi, S., & Dougherty, P. M. (2018) · Pain Management · doi:10.2217/pmt-2018-0020 · Cited by 109
The Nav1.9 Channel Is a Key Determinant of Cold Pain Sensation and Cold Allodynia
Lolignier, S., Bonnet, C., Gaudioso, C., Noël, J., Ruel, J., Amsalem, M., Ferrier, J., Rodat‐Despoix, L., Bouvier, V., Aissouni, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.027 · Cited by 108
Mannelli, L. D. C., Zanardelli, M., Failli, P., & Ghelardini, C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.019 · Cited by 107
Zaks‐Zilberman, M., Zaks, T. Z., & Vogel, S. N. (2001) · Cytokine · doi:10.1006/cyto.2001.0935 · Cited by 106
Johnson, D. C., Corthals, S. L., Walker, B. A., Ross, F. M., Gregory, W. M., Dickens, N. J., Lokhorst, H. M., Goldschmidt, H., Davies, F. E., Durie, B. G. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0792 · Cited by 104
Illias, A. M., Gist, A. C., Zhang, H., Kosturakis, A. K., & Dougherty, P. M. (2018) · Pain · doi:10.1097/j.pain.0000000000001212 · Cited by 104
Gebremedhn, E. G., Shortland, P. J., & Mahns, D. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4185-0 · Cited by 102
Fernyhough, P., Smith, D. R., Schapansky, J., der Ploeg, R. V., Gardiner, N. J., Tweed, C. W., Kontos, A., Freeman, L. J., Purves-Tyson, T. D., & Glazner, G. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3127-04.2005 · Cited by 101
Wahlman, C., Doyle, T. M., Little, J. W., Luongo, L., Janes, K., Chen, Z., Esposito, E., Tosh, D. K., Cuzzocrea, S., Jacobson, K. A., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001177 · Cited by 94
Taxane induced neuropathy in patients affected by breast cancer: Literature review
Iuliis, F. D., Taglieri, L., Salerno, G., Lanza, R., & Scarpa, S. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.04.011 · Cited by 93
Hu, L.-Y., Zhou, Y., Cui, W., Hu, X., Du, L., Mi, W., Chu, Y., Wu, G.-C., Wang, Y., & Mao‐Ying, Q. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.011 · Cited by 92
Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function
Yang, Y., Luo, L., Cai, X., Fang, Y., Wang, J., Chen, G., Yang, J., Zhou, Q., Sun, X., Cheng, X., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.007 · Cited by 87
Painful peripheral neuropathy and sodium channel mutations
Hoeijmakers, J. G. J., Faber, C. G., Merkies, I. S. J., & Waxman, S. G. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.056 · Cited by 84
Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin
Alejandro, L. M., Behrendt, C. E., Chen, K., Openshaw, H., & Shibata, S. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318246b50d · Cited by 83
Poupon-Bejuit, L., Lamoine, S., Pereira, V., Barrière, D. A., Lolignier, S., Giraudet, F., Aissouni, Y., Méleine, M., Prival, L., Richard, D., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.026 · Cited by 80
Peripheral Neuropathy in Patients With Colorectal Cancer Receiving Oxaliplatin
Tofthagen, C., McAllister, R. D., & McMillan, S. C. (2011) · Clinical journal of oncology nursing · doi:10.1188/11.cjon.182-188 · Cited by 78
Therapy‐related peripheral neuropathy in multiple myeloma patients
Morawska, M., Grząśko, N., Kostyra, M., Wojciechowicz, J., & Hus, M. (2014) · Hematological Oncology · doi:10.1002/hon.2149 · Cited by 77
Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain
Salvemini, D., Doyle, T. M., Kress, M., & Nicol, G. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.12.001 · Cited by 71
Aromolaran, K. A., & Goldstein, P. A. (2017) · Molecular Pain · doi:10.1177/1744806917714693 · Cited by 70
Kober, K. M., Olshen, A. B., Conley, Y. P., Schumacher, M. A., Topp, K. S., Smoot, B. J., Mazor, M. B., Chesney, M. A., Hammer, M. J., Paul, S. M., et al. (2018) · Molecular Pain · doi:10.1177/1744806918816462 · Cited by 69
Heide, R., Bostock, H., Ventzel, L., Grafe, P., Bergmans, J., Fuglsang‐Frederiksen, A., Finnerup, N. B., & Tankişi, H. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.11.015 · Cited by 68
PARP inhibition in platinum-based chemotherapy: Chemopotentiation and neuroprotection
McQuade, R. M., Stojanovska, V., Bornstein, J. C., & Nurgali, K. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.031 · Cited by 68
Paclitaxel‐induced neuropathic pain is age dependent and devolves on glial response
Ruiz‐Medina, J., Baulies, A., Bura, S. A., & Valverde, O. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00172.x · Cited by 65
Identification of drug transporters contributing to oxaliplatin‐induced peripheral neuropathy
Fujita, S., Hirota, T., Sakiyama, R., Baba, M., & Ieiri, I. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14607 · Cited by 65
Nudelman, K. N. H., McDonald, B. C., Wang, Y., Smith, D. J., West, J. D., O’Neill, D. P., Zanville, N., Champion, V. L., Schneider, B. P., & Saykin, A. J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.1276 · Cited by 63
Chen, K., Zhang, Z., Liao, M., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.03.029 · Cited by 61
Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice
Park, H. J., Stokes, J. A., Corr, M., & Yaksh, T. L. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2304-9 · Cited by 61
Chemotherapy-induced peripheral neuropathies in hematological malignancies
Jongen, J. L. M., Broijl, A., & Sonneveld, P. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1632-x · Cited by 59
Xu, D., Zhao, H., Gao, H. T., Zhao, H., Liu, D., & Li, J. (2018) · Molecular Pain · doi:10.1177/1744806918783535 · Cited by 59
Pulvers, J. N., & Marx, G. M. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12694 · Cited by 56
Paclitaxel inhibits mRNA transport in axons
Bobylev, I., Joshi, A. R., Barham, M., Ritter, C., Neiss, W. F., Höke, A., & Lehmann, H. C. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.006 · Cited by 55
Prince, H. M., Schenkel, B., & Mileshkin, L. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190601001904 · Cited by 53
Peng, L., Bu, Z., Ye, X., Zhou, Y., & Zhao, Q. D. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12407 · Cited by 53
Deuis, J. R., Lim, Y. L., de Sousa, S. R., Lewis, R. J., Alewood, P. F., Cabot, P. J., & Vetter, I. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou048 · Cited by 52
Mols, F., van de Poll-Franse, L. V., Vreugdenhil, G., Beijers, A. J. M., Kieffer, J. M., Aaronson, N. K., & Husson, O. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.09.020 · Cited by 52
Wang, Y., Li, Y., Cui, W., Li, L., Zhang, Z., Tian, B., & Zhang, G. (2017) · Inflammation · doi:10.1007/s10753-017-0645-y · Cited by 52
Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.
Argyriou, A. A., Zolota, V., Kyriakopoulou, O., & Kalofonos, H. P. (2010) · PubMed · Cited by 51
Magrangeas, F., Kuiper, R., Avet‐Loiseau, H., Gouraud, W., Guérin‐Charbonnel, C., Ferrer, L., Aussem, A., Elghazel, H., Suhard, J., Sakissian, H. D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3163 · Cited by 51
Roles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy
Nakagawa, T., & Kaneko, S. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00243 · Cited by 50
Li, Y.-Y., Li, H., Liu, Z.-L., Li, Q., Qiu, H.-W., Zeng, L., Yang, W., Zhang, X., & Li, Z. (2017) · Molecular Pain · doi:10.1177/1744806917747425 · Cited by 50
Vincristine exacerbates asymptomatic Charcot–Marie–Tooth disease with a novel EGR2 mutation
Nakamura, T., Hashiguchi, A., Suzuki, S., Uozumi, K., Tokunaga, S., & Takashima, H. (2012) · Neurogenetics · doi:10.1007/s10048-012-0313-1 · Cited by 49
Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype
Lopus, M., Smiyun, G., Miller, H. P., Oroudjev, E., Wilson, L., & Jordan, M. A. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2863-z · Cited by 49
Oveissi, V., Ram, M., Bahramsoltani, R., Ebrahimi, F., Rahimi, R., Naseri, R., Belwal, T., Devkota, H. P., Abbasabadi, Z., & Farzaei, M. H. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00255-6 · Cited by 47
White, F. A., & Miller, R. J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.03.007 · Cited by 44
Wang, J., Udd, K. A., Vidisheva, A., Swift, R. A., Spektor, T. M., Bravin, E., Ibrahim, E. N., Treisman, J. S., Masri, M., & Berenson, J. R. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3126-1 · Cited by 44
Huang, Z.-Z., Li, D., Ouyang, H., Liu, C., Liu, X., Ma, C., Wei, J., Liu, Y., & Xin, W. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001084 · Cited by 44
The Dihydroxy Metabolite of the Teratogen Thalidomide Causes Oxidative DNA Damage
Wani, T. H., Chakrabarty, A., Shibata, N., Yamazaki, H., Guengerich, F. P., & Chowdhury, G. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00127 · Cited by 43
Sharawy, N., Rashed, L. A., & Youakim, M. F. (2015) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2015.02.003 · Cited by 42
Thalidomide in multiple myeloma
Richardson, P. G. G., Hideshima, T., & Anderson, K. C. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00168-3 · Cited by 41
Systemic chemotherapy decreases brain glucose metabolism
Horky, L. L., Gerbaudo, V. H., Zaitsev, A., Plesniak, W., Hainer, J. M., Govindarajulu, U. S., Kikinis, R., & Dietrich, J. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.121 · Cited by 39
Wu, B.-Y., Liu, C., Su, Y., Chen, S., Chen, Y., & Tsai, M.-Y. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.11.022 · Cited by 39
Jones, D., Zhao, F., Brell, J. M., et al. (2014) · Journal of Cancer Survivorship · doi:10.1007/s11764-014-0379-x · Cited by 38
Bortezomib‐induced inflammatory neuropathy
Saifee, T. A., Elliott, K. J., Lunn, M. P., Blake, J. C., Reilly, M. M., Rabin, N. K., Yong, K., D’Sa, S., & Brandner, S. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00287.x · Cited by 37
Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas
Grouzmann, E., Gicquel, C., Plouin, P., Schlumberger, M. J., Comoy, E., & Bohuon, C. (1990) · Cancer · doi:10.1002/1097-0142(19901015)66:8<1697::aid-cncr2820660808>3.0.co;2-g · Cited by 36
Thibault, K., Calvino, B., Dubacq, S., Roualle-de-Rouville, M., Sordoillet, V., Rivals, I., & Pezet, S. (2012) · Pain · doi:10.1016/j.pain.2012.04.016 · Cited by 34
Pan, L., Song, K., Hu, F. Z., Sun, W., & Lee, I. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.009 · Cited by 33
Yilmaz, E., Watkins, S. C., & Gold, M. S. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.01.005 · Cited by 32
Wang, J., Zhang, X., Tao, R., Zhang, J., Liu, L., Jiang, Y., Ma, S.-H., Lin-xia, S., & Xia, L. (2017) · Molecular Pain · doi:10.1177/1744806917726256 · Cited by 32
Meta-analysis of incidence and risk of peripheral neuropathy associated with intravenous bortezomib
Peng, L., Ye, X., Zhou, Y., Zhang, J., & Zhao, Q. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2648-2 · Cited by 31
Ixabepilone‐induced mitochondria and sensory axon loss in breast cancer patients
Ebenezer, G. J., Carlson, K.-S., Donovan, D., Cobham, M. V., Chuang, E., Moore, A. L., Cigler, T., Ward, M. M., Lane, M. E., Ramnarain, A., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.90 · Cited by 30
Chemotherapy-induced peripheral neuropathy
Zhang, X., Chen, W., & Huang, W. (2017) · Biomedical Reports · doi:10.3892/br.2017.851 · Cited by 30
García‐Sánz, R., Corchete, L. A., Alcoceba, M., Chillón, C., Jiménez, C., Prieto, I., García‐Álvarez, M., Puig, N., Rapado, I., Barrio, S., et al. (2016) · Hematological Oncology · doi:10.1002/hon.2337 · Cited by 29
Andoh, T., Uta, D., Kato, M., Toume, K., Komatsu, K., & Kuraishi, Y. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00899 · Cited by 29
Hu, B., Zhou, Q., Wu, T., Zhuang, L., Yi, L., Cao, J., Yang, X., & Wang, J. (2017) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp202714 · Cited by 28
Miyake, T., Nakamura, S., Meng, Z., Hamano, S., Inoue, K., Numata, T., Takahashi, N., Nagayasu, K., Shirakawa, H., Mori, Y., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00878 · Cited by 28
Paclitaxel alters sensory nerve biomechanical properties
Bober, B. G., & Shah, S. B. (2015) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2015.07.020 · Cited by 27
do Nascimento, F. P., Macedo-Júnior, S. J., Borges, F. R. M., Cremonese, R. P., da Silva, M. D., Cerutti, M. L., Martins, D. F., Rodrigues, A. L. S., & Santos, A. R. S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.044 · Cited by 26
Masocha, W., & Thomas, A. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.02.007 · Cited by 18
Liu, H., Xu, R., & Huang, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3738 · Cited by 17
Altered Expression of Cytoskeletal and Axonal Proteins in Oxaliplatin-Induced Neuropathy
Sanna, M. D., Ghelardini, C., & Galeotti, N. (2016) · Pharmacology · doi:10.1159/000443898 · Cited by 15
Chemotherapy-Induced Neuropathic Pain
Raffa, R. B., Langford, R. M., Pergolizzi, J. V., Porreca, F., & Tallarida, R. J. (2012) · CRC Press eBooks · doi:10.1201/b12366 · Cited by 13
Emery, E. C., & Wood, J. N. (2018) · New England Journal of Medicine · doi:10.1056/nejmcibr1803720 · Cited by 12
Nudelman, K. N. H., McDonald, B. C., Wang, Y., Smith, D. J., West, J. D., O’Neill, D. P., Zanville, N., Champion, V. L., Schneider, B. P., & Saykin, A. J. (2016) · PMC · Cited by 5
Cited by
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Chi, K. N., Rathkopf, D., Smith, M. R., Efstathiou, E., Attard, G., Olmos, D., Lee, J. Y., Small, E. J., Pereira de Santana Gomes, A. J., Roubaud, G., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01649 · Cited by 355
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Burgess, J., Ferdousi, M., Gosal, D., Boon, C., Matsumoto, K., Marshall, A., Mak, T., Marshall, A., Frank, B., Malik, R. A., et al. (2021) · Oncology and Therapy · doi:10.1007/s40487-021-00168-y · Cited by 306
Mechanisms of Chemotherapy-Induced Neurotoxicity
Was, H., Borkowska, A., Bagues, A., Tu, L., Liu, J. Y. H., Lu, Z., Rudd, J. A., Nurgali, K., & Abalo, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.750507 · Cited by 285
Effects of NAD+ in Caenorhabditis elegans Models of Neuronal Damage
Lee, Y., Jeong, H., Park, K. H., & Kim, K. W. (2020) · Biomolecules · doi:10.3390/biom10070993 · Cited by 8
Metadata
- Authors
- Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-22
- Volume
- 20
- Issue
- 6
- Pages
- 1451
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2923697933
- Cited by
- 829
- References
- 188
- FWCI
- 29.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.